Outcome After PCI Improved By Personalized Antiplatelet Treatment
8/30/2012
The findings were presented by Dr Jolanta Siller-Matula from Medical University of Vienna. Standard antiplatelet treatment in patients undergoing percutaneous coronary intervention (PCI) consists of a dual antiplatelet therapy with aspirin and an ADP receptor inhibitor such as clopidogrel...
Aspirin May Prolong Prostate Cancer Survival
8/30/2012
Taking a regular dose of aspirin may help men treated for prostate cancer, either with surgery or radiation, live longer, especially if they have the high risk form of the disease. This was the finding of a new study published this week in the Journal of Clinical Oncology...
Preventing Thrombotic And Thromboembolic Complications By Omitting Aspirin From Antiplatelet Regimen
8/30/2012
Lifelong anticoagulation is necessary for the prevention of stroke in patients with rhythm disturbances and with mechanical valves. Patients who have a coronary stent implanted also need the antiplatelet drugs aspirin and clopidogrel to prevent the rare but lethal complication of stent thrombosis...
New Ultraviolet Light Can Pinpoint Location Of Diseases
8/29/2012
A new study published in the Online Early Edition of Proceedings of the National Academy of Sciences reveals that Johns Hopkins researchers have developed a synthetic protein, which, when activated under ultraviolet lighting, can show doctors exactly where certain medical disorders are located, such as arthritis and cancer...
Tumor Formation Blocked By Turning On Key Enzyme
8/29/2012
Drug-like molecule restores normal cell metabolism, preventing cancer cells from growing. Unlike ordinary cells, cancer cells devote most of their energy to reproducing themselves. To do this, they must trigger alternative metabolic pathways that produce new cellular building blocks, such as DNA, carbohydrates and lipids...
Scientists at the Oswaldo Cruz Foundation and Federal University of Minas Gerais, led by Dr. Andrea Teixeira-Carvalho and Dr. Monica Cristina de Oliveira, have developed and characterized a circulating and pH-sensitive liposome containing cisplatin (SpHL-CDDP) aiming to promote the release of cisplatin near the tumor as well as decreasing toxicity...
Cancer Researchers Highlight Gating Factors In The Success Or Failure Of Novel Cancer Vaccines
8/29/2012
In one of the most comprehensive peer-reviewed discussions on cancer vaccines and immunotherapeutics, a Special Focus in the journal Human Vaccines & Immunotherapeutics provides a critical view on cancer vaccines and a discussion on best approaches for the future...
First-Of-Its-Kind Study Finds Lack Of Sleep To Be A New Risk Factor For Aggressive Breast Cancers
8/29/2012
Lack of sleep is linked to more aggressive breast cancers, according to new findings published in the August issue of Breast Cancer Research and Treatment by physician-scientists from University Hospitals Case Medical Center's Seidman Cancer Center and Case Comprehensive Cancer Center at Case Western Reserve University...
Technique To Repair Ruptured Abdominal Aortic Aneurysms Questioned By Study
8/29/2012
A new study raises a cautionary note about the increasing use of a minimally invasive procedure to repair ruptured abdominal aortic aneurysms, according to vascular surgeon Dr. Jae Sung Cho of Loyola University Medical Center. A ruptured abdominal aortic aneurysm (AAA) causes massive internal bleeding that requires immediate emergency surgery to save the patient...
Prostate Cancer Care's Racial Disparities Revealed By Study
8/29/2012
A study led by investigators from Vanderbilt-Ingram Cancer Center (VICC), Nashville, Tenn., finds that black men with prostate cancer receive lower quality surgical care than white men. The racial differences persist even when controlling for factors such as the year of surgery, age, comorbidities and insurance status. Daniel Barocas, M.D...